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A novel interleukin-8 polymorphism is associated with severe The inflammatory response to immune complex depo-
systemic lupus erythematosus nephritis. sition in the kidney is a major determinant of the severity
Background. Interleukin-8 (IL-8) is a potent neutrophil che- of renal injury. While a number of factors influence themokine that has been implicated in the pathogenesis of renal
inflammatory response, the role of an individual’s geneticinflammation in human glomerulonephritis. To explain inter-
background has recently received increasing attention.patient variations in renal inflammation during diseases such
as systemic lupus erythematosus (SLE), it was postulated that It has been postulated that genetic variations affecting
the promoter region of the IL-8 gene contains polymorphic cytokine transcription occur in the regulatory regions of
residues that influence the level of IL-8 expression in response
pro-inflammatory cytokine genes, and that such poly-to immune-complex deposition, and thereby affect the severity
morphisms may control the level of inflammation. Con-of renal injury. This study was undertaken to identify polymor-
phisms in the 5-flanking region of the IL-8 gene that correlate sistent with this, polymorphisms have been described in
with the severity of SLE nephritis. the promoter regions of several cytokine and chemokine
Methods. A 1526 base pair segment of the IL-8 5-flanking genes that enhance transcriptional activity, increase cyto-region was PCR amplified from the genomic DNA of 100 indi-
kine production, and are associated with disease pheno-viduals and sequenced on an automated capillary electrophor-
esis system. Sequence data were compared with the published type [1–10].
IL-8 sequence to identify polymorphisms. Allelic variations With respect to glomerulonephritis, genetic variations
were verified by cloning and re-sequencing, and also by restric- in chemokine genes may be particularly relevant, becausetion enzyme analysis. Patients with SLE nephritis were geno-
chemokines mediate glomerular leukocyte infiltrationtyped for IL-8 polymorphisms, and associations between spe-
[11]. The neutrophil chemokine interleukin-8 (IL-8) hascific alleles and severity of SLE nephritis [based on the World
Health Organization (WHO) classification] were determined. been one of the most intensely studied chemotactic fac-
Results. Three single nucleotide polymorphisms were iden- tors in renal disease. IL-8 is up-regulated in the kidney
tified in the IL-8 flanking region. Labeled relative to the
in IgA nephropathy, the nephritis of systemic lupus ery-IL-8 translational start site, these are T845C, T738A, and
thematosus (SLE), and anti-neutrophil cytoplasmic anti-A353T. T845C and T738A are novel, and found primarily
in African Americans. The C for T change at position 845 body (ANCA)–associated vasculitis, and urinary IL-8
was found to be 3.6 to 7.5 times more frequent in African levels tend to mirror disease activity and glomerular leu-
Americans with severe (WHO Class IV) SLE nephritis, than kocyte infiltration [12–15]. Neutralization of IL-8 or itsin African American controls, or patients with less severe forms
equivalent in animal models of immune complex-medi-of SLE nephritis, respectively.
Conclusions. IL-8 845C might predispose African Ameri- ated glomerulonephritis attenuates glomerular neutro-
cans with SLE nephritis to more severe renal injury, perhaps phil infiltration and glomerular injury, as reflected by a
by influencing IL-8 expression. Genotyping patients with glo- decrease in proteinuria [16, 17]. At present there is lit-merulonephritis for IL-8 polymorphisms may be useful in pre-
tle information on IL-8 regulatory region polymor-dicting disease outcome and individualizing immunosuppres-
phisms, and no information on such polymorphisms insive therapy.
renal disease.
This investigation was undertaken to identify singleKey words: chemokine, single nucleotide polymorphism, SLE, glomer-
ulonephritis. nucleotide polymorphisms (SNPs) in the 5-flanking re-
gion of the IL-8 gene. In a population of healthy Cau-Received for publication December 18, 2001
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of patients with SLE demonstrated a strong association Statistical analysis
of the variant allele at position845 with severe glomer- Differences in allele frequencies among specified pop-
ulonephritis in African Americans. These data suggest ulations were analyzed in 2  2 contingency tables by
that the SNP at IL-8845 may predispose African Ameri- Fisher’s exact test. A two-sided P value was calculated,
can with SLE nephritis to more severe renal injury, per- and considered significant if less than 0.05. For significant
haps by altering IL-8 expression. results an odds ratio (OR) was also calculated.
METHODS RESULTS
Study populations Identification of IL-8 regulatory region polymorphisms
After informed consent, blood for genomic DNA was Using the genomic DNA of 100 individuals, 1526 bases
obtained from 162 healthy individuals (84 Caucasians, upstream of the IL-8 translational start site were com-
65 African Americans, and 15 Asians), and 167 patients pletely sequenced. Several discrepancies were found
with SLE (111 Caucasians and 56 African Americans), as when these sequences were compared to the published
approved by the Ohio State University Internal Review sequence ([18], GenBank accession number M28130).
Board. Seventy eight percent of the control population Counting from the first base of the start codon, these
was female, compared to 89% of the SLE cohort. The differences included (1) deletion of the guanine (G) and
diagnosis of SLE was established using the 1982 revised thymine (T) residues at positions 1305 and 1304,
American College of Rheumatology criteria. The major- respectively; (2) substitution of adenine (A) for the G
ity of patients in the SLE cohort had renal involvement at position 1181, and G for the A at position 1180;
(120 patients), which was verified in 101 patients by renal (3) Insertion of a cytosine (C) between residues671 and
biopsy. In biopsied patients, the histologic severity of 670, and residues 603 and 602; (4) Substitution of
lupus nephritis was classified according to the modified A for T at position 645, and T for A at position 644;
(1995) World Health Organization (WHO) schema. (5) Substitution of C for A at position 632, and T for
C at position 631; (6) Insertion of A between residues
Isolation and sequencing of genomic DNA
390 and 389. These differences were present in all
Genomic DNA was extracted from peripheral blood the samples, and were therefore not considered poly-
leukocytes of ethylenediaminetetraacetic acid (EDTA)- morphisms. Three biallelic polymorphisms were identi-
treated whole blood (1 mL) using DNAzol (Gibco, Grand fied (wild type→variant): A353T, T738A, and T845C
Island, NY, USA). Based on the published sequence (Fig. 1A). IL-8 A353T has been described in a Euro-
([18], GenBank accession number M28130), a 1526 base pean Caucasian population [19]; the other SNPs are novel.
pair segment of the IL-8 5-flanking region between The numeric position of these polymorphisms takes into
nucleotides 57 and 1583 relative to the translational account the insertions and deletions noted above.
start codon was analyzed. This segment contains several Analysis of the sequence surrounding each SNP pre-
regulatory elements important for induction of IL-8 tran- dicted that these polymorphisms would affect specific
scription [18]. The IL-8 5-flanking region was PCR- restriction enzyme sites. Considering the insertions and
amplified from genomic DNA using the forward primer deletions found in the IL-8 flanking region, Vsp I cut
5-GAATTCAGTAACCCAGGCAT-3, and the the 1527 bp segment into 791 and 736 bp fragments when
reverse primer 5-AAGCTTGTGTGCTCTGCTGTC T was present at position 845, but did not cut when C
TCT-3. After 40 cycles the reaction was terminated and was present at this position (Fig. 1B). Position 738 is
excess primers and dNTPs were removed by incubation located within an Xba I site. There is another Xba I site
with exonuclease I and shrimp alkaline phosphatase downstream of 738. Digestion with Xba I resulted in
(Amersham Pharmacia, Piscataway, NJ, USA). The pu- 847, 365, and 317 bp fragments when T was present at
rified PCR product was sequenced on an automated cap- 738. If A was present, Xba I did not cut at 738, but
illary electrophoresis system (ABI PRISM 3100 Genetic the other Xba I site was intact, yielding 1212 and 317 bp
Analyzer; Applied Biosystems, Foster City, CA, USA) fragments (Fig. 1B). Mfe I cut the 1527 bp segment into
after dRhodamine cycle sequencing terminator dye la- 1230 and 297 bp fragments when A was present at posi-
beling. Three primers were used that each covered ap- tion 353, but did not cut if T was present (Fig. 1B).
proximately 500 sequential bases along the length of the Restriction analysis correlated with direct DNA se-
IL-8 5-flanking region. The fluorescent sequence data quencing, confirming the presence of these SNPs.
were analyzed using 3100 Sequencing Data Collection
Allele frequencies in normal populationsSoftware (Applied Biosystems) and expressed as an elec-
tropherogram. Selected DNA samples were cloned and Using restriction analysis, the IL-8 genotypes of nor-
expanded in DH5 bacteria as previously described [9], mal individuals were determined, and allele frequencies
for each SNP calculated. As illustrated in Table 1, thereand re-sequenced to verify identified polymorphisms.
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Fig. 1. IL-8 regulatory region polymorphisms.
(A) Sequence analysis of the IL-8 gene 5-flanking
region. Genomic DNA from selected individuals
was cloned and sequenced to illustrate the single
nucleotide polymorphisms T845C, T738A, and
A353T. Representative electropherograms dem-
onstrating the sequence immediately surrounding
each polymorphic allele (arrow) are shown. (B)
Restriction analysis for IL-8 genotyping. The
SNPs at positions 845, 738, and 353 are lo-
cated in Vsp I, Xba I, and Mfe I sites. These re-
striction sites are intact if the wild-type alleles are
present, but are disrupted if the variant alleles
are present. The ethidium bromide-stained gel
shows the banding pattern for each SNP after
digestion of genomic DNA from individuals ho-
mozygous for the wild-type allele or heterozygous
for the variant allele. A 100 base-pair DNA ladder
is also shown.
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Table 1. Allele frequencies of IL-8 polymorphisms DISCUSSION
in healthy individuals
This investigation provides the first evidence that a
Caucasian African American Asian genetic variant of a chemokine gene may be associatedSite Allele N  84 N  65 N  15
with the severity of SLE nephritis in African Americans.
845 T 0.994 0.95 1
We have identified two novel polymorphisms in theC 0.006a 0.05 0
738 T 1 0.92 1 5-flanking region of the IL-8 gene that are mainly found
A 0b 0.08 0 in African Americans. Furthermore, the frequency of
353 A 0.47b 0.80 0.35
IL-8845C is 3.6-fold higher in African Americans withT 0.53 0.20 0.65
severe lupus nephritis (WHO Class IV) than in controls,a P  0.03; b P  0.0003 vs. African American
and 7.5-fold higher than in patients with less inflamma-
tory forms of SLE nephritis (WHO Classes I-III, and
were large differences in the frequencies of these alleles V). IL-8 738A shows a tendency toward under-repre-
among Caucasians, African Americans, and Asians. IL-8 sentation in African Americans with non-renal SLE and
T738A and T845C were found primarily in African less severe forms of SLE nephritis than Class IV. IL-8
Americans. No individuals homozygous for the variant A353T was previously described in two British cohorts
alleles of IL-8 T845C and T738A were found in the with allele frequencies similar to those in our Caucasian
control group. The A and T allele frequencies for the cohort [19, 20]. There is no apparent association of IL-8
353 SNP were approximately equal in Caucasians, A353T with severity of renal disease in SLE.
whereas the A allele was dominant in African Ameri- It is tempting to speculate that IL-8 845C predis-
cans. The frequency of these SNPs in African American poses African Americans with SLE nephritis to more
and Caucasian blood donors did not deviate from Hardy- severe renal injury by influencing IL-8 expression. This
Weinberg equilibrium. is not inconceivable, as the presence of this allele creates
a new cAMP response element-like binding site on the
Allele frequencies in SLE populations antisense strand in this region of the IL-8 gene [21, 22].
Patients with SLE were genotyped for IL-8 SNPs using We are currently testing the effect of this SNP on pro-
restriction analysis (Table 2). Compared to healthy indi- moter activity in reporter assays. The role of T738A
viduals (Table 1), African American patients with severe, in African Americans with SLE is less clear. The T to
inflammatory SLE nephritis (WHO Class IV) had a sig- A change alters a serum response factor-related protein
nificantly higher frequency of IL-8 845C (P  0.014, (RSRFC4) binding site at an invariant consensus position
OR  4.24). Additionally, the odds of having IL-8 [23], and thus could affect IL-8 expression. Although the
845C were approximately ninefold higher in African tendency toward under-representation of IL-8 738A
Americans with Class IV SLE nephritis than patients in SLE patients who do not have Class IV nephritis
with non-Class IV nephritis (Table 2, OR 8.9). Patients suggests this allele may facilitate development of more
with SLE and renal manifestations who were not biop- severe nephritis, a larger patient population will be re-
sied (N  10) were excluded from this analysis. Of 9 quired to test this association.
patients with non-renal SLE, only one was heterozygous The lack of a correlation between IL-8 353A and
for T845C. IL-8 845 showed no correlation with se- severity of SLE nephritis raises an interesting question.
verity of SLE nephritis in Caucasians (Table 2). In total We have assumed that patients who produce high levels
(all cohorts) there were 20 individuals heterozy- of IL-8 are at increased risk for severe nephritis. How-
gous for T845C. The IL-8 genotypes of these 20 people ever, it has recently been shown that leukocytes from
were T/C|T/T|A/A (N  15, alleles at positions individuals homozygous for 353A tend to produce
845|738|353, respectively), T/C|T/T|A/T (N  4), more IL-8 than leukocytes from TT homozygotes [20],
and T/C|T/A|A/A (N  1). The 5 DNA samples con- perhaps because the presence of the T allele causes a
taining 845C plus a variant allele at 738 or 353 two-nucleotide mismatch in a potential homeodomain
(CdxA-like) protein binding site [24]. These data chal-were cloned and re-sequenced. In this population845C
was always associated with 738T and 353A, sug- lenge the idea that high IL-8 levels predispose to more
severe disease, and raise the possibility that inadequategesting CTA is a specific IL-8 haplotype.
IL-8 353 did not correlate with severity of SLE ne- IL-8 production is deleterious. Consistent with this possi-
bility, the 353T allele shows a trend toward higherphritis in Caucasians or African Americans. Similarly,
the frequency of IL-8738A was not different in healthy representation in patients with Class IV SLE nephritis,
although this does not reach statistical significance. TheAfrican Americans or patients with Class IV nephritis.
However, this allele appeared to be under-represented exact relationship of IL-8 levels to disease phenotype
will be clarified as we determine the effect of IL-8 poly-in patients with non-Class IV nephritis (Table 2), and
was not present in 9 patients with non-renal SLE (not morphisms that are associated with a specific phenotype
on IL-8 expression.shown), although this trend did not reach significance.
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Table 2. Allele frequencies of IL-8 polymorphisms in patients with SLE nephritis
Caucasian Caucasian African American African American
Class IV nephritis non-Class IV nephritis Class IV nephritis non-Class IV nephritis
Site Allele N  35 N  29 N  18 N  19
845 T 1 0.97 0.81 0.97
C 0 0.03 0.19a 0.03
738 T 1 1 0.94 0.97
A 0 0 0.06 0.03
353 A 0.43 0.52 0.75 0.87
T 0.57 0.48 0.25 0.13
a P  0.03 vs. African Americans with non-Class IV nephritis
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